|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.60 USD | +0.39% |
|
+1.59% | +36.17% |
| 03-12 | AMREP Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026 | CI |
| 02-19 | Amrep Insider Bought Shares Worth $270,898, According to a Recent SEC Filing | MT |
| Fiscal Period: April | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.08 | 13.85 | 7.96 | 3.98 | 5.9 | |||||
Return on Total Capital | 9.73 | 14.98 | 8.54 | 4.14 | 6.1 | |||||
Return On Equity % | 8.52 | 18.44 | 22.45 | 5.84 | 10.25 | |||||
Return on Common Equity | 8.52 | 18.44 | 22.45 | 5.84 | 10.25 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.11 | 42.67 | 38.83 | 28.17 | 39.01 | |||||
SG&A Margin | 0.93 | 8.57 | 11.24 | 13.38 | 14.65 | |||||
EBITDA Margin % | 36.55 | 34.46 | 27.71 | 15.09 | 24.72 | |||||
EBITA Margin % | 35.17 | 34.1 | 27.58 | 14.8 | 24.36 | |||||
EBIT Margin % | 35.17 | 34.1 | 27.58 | 14.8 | 24.36 | |||||
Income From Continuing Operations Margin % | 18.45 | 25.39 | 44.77 | 13.02 | 25.59 | |||||
Net Income Margin % | 18.45 | 25.39 | 44.77 | 13.02 | 25.59 | |||||
Net Avail. For Common Margin % | 18.45 | 25.39 | 44.77 | 13.02 | 25.59 | |||||
Normalized Net Income Margin | 22.04 | 21.31 | 17.25 | 10.25 | 17.26 | |||||
Levered Free Cash Flow Margin | 23.06 | 9.68 | 8.62 | 8.7 | 12.52 | |||||
Unlevered Free Cash Flow Margin | 22.97 | 9.55 | 8.62 | 8.7 | 12.52 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.41 | 0.65 | 0.46 | 0.43 | 0.39 | |||||
Fixed Assets Turnover | 313.04 | 83.47 | 34.41 | 31.59 | 24.64 | |||||
Receivables Turnover (Average Receivables) | 415.22 | 1.44K | - | - | - | |||||
Inventory Turnover (Average Inventory) | 0.47 | 0.58 | 0.45 | 0.56 | 0.46 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 18.08 | 8.68 | 18.33 | 20.79 | 28.68 | |||||
Quick Ratio | 5.56 | 1.64 | 4.21 | 6.36 | 10.62 | |||||
Operating Cash Flow to Current Liabilities | 2.82 | 1.61 | 1.34 | 2.29 | 2.73 | |||||
Days Sales Outstanding (Average Receivables) | 0.88 | 0.25 | - | - | - | |||||
Days Outstanding Inventory (Average Inventory) | 777.26 | 625.81 | 814.37 | 652.76 | 799.23 | |||||
Average Days Payable Outstanding | 16.6 | 16.92 | 31.74 | 19.46 | 19.94 | |||||
Cash Conversion Cycle (Average Days) | 761.54 | 609.15 | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 3.98 | 2.58 | 0.13 | 0.09 | 0.05 | |||||
Total Debt / Total Capital | 3.82 | 2.52 | 0.12 | 0.09 | 0.05 | |||||
LT Debt/Equity | 3.98 | 2.58 | 0.13 | 0.09 | 0.05 | |||||
Long-Term Debt / Total Capital | 3.82 | 2.52 | 0.12 | 0.09 | 0.05 | |||||
Total Liabilities / Total Assets | 8.71 | 12.38 | 4.22 | 3.89 | 2.85 | |||||
EBIT / Interest Expense | 352.32 | - | - | - | - | |||||
EBITDA / Interest Expense | 369.02 | - | - | - | - | |||||
(EBITDA - Capex) / Interest Expense | 368.9 | - | - | - | - | |||||
Total Debt / EBITDA | 0.24 | 0.1 | 0.01 | 0.01 | 0.01 | |||||
Net Debt / EBITDA | -1.44 | -0.63 | -1.47 | -3.79 | -3.19 | |||||
Total Debt / (EBITDA - Capex) | 0.24 | 0.11 | 0.01 | 0.01 | 0.01 | |||||
Net Debt / (EBITDA - Capex) | -1.44 | -0.67 | -1.48 | -4.02 | -3.35 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 113.33 | 55.93 | -17.39 | 5.53 | -3.26 | |||||
Gross Profit, 1 Yr. Growth % | 189.46 | 84.26 | -29.1 | -23.42 | 33.94 | |||||
EBITDA, 1 Yr. Growth % | -297.35 | 124.23 | -37.34 | -42.54 | 58.51 | |||||
EBITA, 1 Yr. Growth % | -277.07 | 135.47 | -36.97 | -43.38 | 59.26 | |||||
EBIT, 1 Yr. Growth % | -277.07 | 135.47 | -36.97 | -43.38 | 59.26 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -225.22 | 114.58 | 37.37 | -69.3 | 90.07 | |||||
Net Income, 1 Yr. Growth % | -225.22 | 114.58 | 37.37 | -69.3 | 90.07 | |||||
Normalized Net Income, 1 Yr. Growth % | -285.32 | 134.52 | -36.94 | -37.29 | 62.91 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -230.14 | 132.63 | 85.97 | -69.59 | 89.6 | |||||
Accounts Receivable, 1 Yr. Growth % | -76.28 | 35.14 | - | - | - | |||||
Inventory, 1 Yr. Growth % | 4 | 20.98 | -2.42 | 0.55 | 1.16 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -22.22 | 1.14K | 4.26 | 25.21 | 23.06 | |||||
Total Assets, 1 Yr. Growth % | 0.72 | -2.52 | 22.1 | 5.98 | 8.91 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.02 | -6.44 | 33.47 | 6.35 | 10.09 | |||||
Common Equity, 1 Yr. Growth % | 5.02 | -6.44 | 33.47 | 6.35 | 10.09 | |||||
Cash From Operations, 1 Yr. Growth % | 1.55K | 22.74 | -58.72 | 67.69 | -4.41 | |||||
Capital Expenditures, 1 Yr. Growth % | -44.44 | 25.64K | -89.82 | 248.85 | 27.57 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 27.3 | 0.52 | -31.22 | 6.54 | 39.17 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 27.98 | -0.32 | -30.26 | 6.54 | 39.17 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 77.25 | 82.38 | 10.22 | -6.63 | 1.04 | |||||
Gross Profit, 2 Yr. CAGR % | 282.46 | 130.94 | 14.3 | -26.32 | 1.28 | |||||
EBITDA, 2 Yr. CAGR % | 135.72 | 70.31 | 18.54 | -40 | -4.57 | |||||
EBITA, 2 Yr. CAGR % | 109.04 | 63.6 | 21.83 | -40.26 | -5.04 | |||||
EBIT, 2 Yr. CAGR % | 109.04 | 63.6 | 21.83 | -40.26 | -5.04 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 73.17 | 63.92 | 71.69 | -35.06 | -23.61 | |||||
Net Income, 2 Yr. CAGR % | 120.02 | 63.92 | 71.69 | -35.06 | -23.61 | |||||
Normalized Net Income, 2 Yr. CAGR % | 111.03 | 67.16 | 21.61 | -37.12 | 1.07 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 76.67 | 73.99 | 108 | -24.79 | -24.06 | |||||
Accounts Receivable, 2 Yr. CAGR % | - | -43.39 | - | - | - | |||||
Inventory, 2 Yr. CAGR % | -1.91 | 12.17 | 8.65 | -0.95 | 0.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | - | 210.13 | 259.07 | 14.25 | 24.13 | |||||
Total Assets, 2 Yr. CAGR % | -1.59 | -0.91 | 9.1 | 13.76 | 7.44 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.53 | -0.88 | 11.75 | 19.14 | 8.2 | |||||
Common Equity, 2 Yr. CAGR % | -0.53 | -0.88 | 11.75 | 19.14 | 8.2 | |||||
Cash From Operations, 2 Yr. CAGR % | 361.51 | 349.78 | -28.82 | -16.8 | 26.61 | |||||
Capital Expenditures, 2 Yr. CAGR % | -20.94 | 1.1K | 411.86 | -40.41 | 110.96 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 4.01 | -8.7 | -16.51 | -14.4 | 21.77 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 3.88 | -8.93 | -16.28 | -13.8 | 21.77 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 64.96 | 69.84 | 37.36 | 8.63 | -5.52 | |||||
Gross Profit, 3 Yr. CAGR % | 128.41 | 199.83 | 55.79 | 0.01 | -10.07 | |||||
EBITDA, 3 Yr. CAGR % | 84.58 | 101.38 | 22.04 | -6.89 | -17.05 | |||||
EBITA, 3 Yr. CAGR % | 70.61 | 87.63 | 19.04 | -5.64 | -17.17 | |||||
EBIT, 3 Yr. CAGR % | 70.61 | 87.63 | 19.04 | -5.64 | -17.17 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 42.32 | 86 | 54.55 | -3.27 | -7.1 | |||||
Net Income, 3 Yr. CAGR % | 214.34 | 118.19 | 54.55 | -3.27 | -7.1 | |||||
Normalized Net Income, 3 Yr. CAGR % | 70.66 | 88.66 | 20.78 | -2.48 | -13.64 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 43.72 | 93.64 | 77.9 | 9.58 | 2.36 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | - | - | - | - | |||||
Inventory, 3 Yr. CAGR % | -1.9 | 5.19 | 7.08 | 5.88 | -0.25 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | 115.64 | 152.73 | 17.12 | |||||
Total Assets, 3 Yr. CAGR % | -2.86 | -1.9 | 6.23 | 8.05 | 12.12 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.67 | -2.54 | 9.46 | 9.92 | 16.05 | |||||
Common Equity, 3 Yr. CAGR % | 0.67 | -2.54 | 9.46 | 9.92 | 16.05 | |||||
Cash From Operations, 3 Yr. CAGR % | 187.43 | 196.79 | 102.89 | -5.28 | -12.86 | |||||
Capital Expenditures, 3 Yr. CAGR % | -54.19 | 443.87 | 144.16 | 350.45 | -23.2 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -6.49 | -10.86 | -16.7 | -9.44 | 0.65 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -6.6 | -11.24 | -16.45 | -9.27 | 1.12 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.78 | 8.86 | 40.39 | 32.13 | 21.48 | |||||
Gross Profit, 5 Yr. CAGR % | 42.11 | 33.11 | 73.16 | 71.03 | 31.14 | |||||
EBITDA, 5 Yr. CAGR % | 35.58 | 77.7 | 42.09 | 24.07 | 10.61 | |||||
EBITA, 5 Yr. CAGR % | 24.26 | 161.56 | 36.46 | 18.71 | 8.75 | |||||
EBIT, 5 Yr. CAGR % | 17.95 | 159.51 | 36.46 | 18.71 | 8.75 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -6.28 | 302.58 | 53.42 | 22.1 | 16.59 | |||||
Net Income, 5 Yr. CAGR % | -6.28 | 302.58 | 146.79 | 34.37 | 16.59 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.4 | 110.62 | 36.42 | 21.57 | 12.47 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -5.67 | 311.99 | 66.62 | 32.65 | 26.56 | |||||
Accounts Receivable, 5 Yr. CAGR % | -65.22 | -62.08 | - | - | - | |||||
Inventory, 5 Yr. CAGR % | -2.05 | 3.7 | 2.19 | 2.69 | 4.54 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -60.73 | -33.75 | - | - | 72.9 | |||||
Total Assets, 5 Yr. CAGR % | -4.19 | -2.31 | 1.76 | 4.09 | 6.71 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.42 | -0.4 | 4.96 | 5.61 | 8.96 | |||||
Common Equity, 5 Yr. CAGR % | 1.42 | -0.4 | 4.96 | 5.61 | 8.96 | |||||
Cash From Operations, 5 Yr. CAGR % | 29.46 | 8.2 | 64.46 | 78.45 | 68.01 | |||||
Capital Expenditures, 5 Yr. CAGR % | -63.74 | 38.89 | 20.3 | 124.58 | 130.3 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.12 | -3.87 | -17.98 | -12.15 | -3.04 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 8.71 | -4.67 | -17.97 | -12.13 | -2.86 |
- Stock Market
- Stocks
- AXR Stock
- Financials AMREP Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















